A. Shamardina

Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study

N. Myakova, A. Maschan, L. Shelikhova, 2014, Journal of pediatric hematology/oncology.

Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia

G. Henze, A. Stackelberg, A. Maschan, 2008, Leukemia.

[Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus].

R. Hartmann, N. Miakova, O. Aleinikova, 2002, Voprosi onkologii.

[Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000].

R. Hartmann, S. Varfolomeeva, N. Miakova, 2002, Voprosi onkologii.

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

G. Henze, J. Boos, A. von Stackelberg, 2019, Journal of Cancer Research and Clinical Oncology.

[Age-related characteristics of the efficacy of different glucocorticosteroids in the therapy of acute lymphoblastic leukemia].

G. Henze, G. Tallen, C. Bührer, 2015, Terapevticheskii arkhiv.

Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002

G. Henze, N. Myakova, G. Tallen, 2015, Leukemia.

[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].

G. Henze, R. Herold, S. Varfolomeeva, 2007, Terapevticheskii arkhiv.